Rapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysis.

Rapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysis.

<h4>Background</h4>Xpert MTB/RIF (Xpert) is a promising new rapid diagnostic technology for tuberculosis (TB) that has characteristics that suggest large-scale roll-out. However, because the test is expensive, there are concerns among TB program managers and policy makers regarding its a...

Full description

Bibliographic Details
Main Authors: Anna Vassall, Sanne van Kampen, Hojoon Sohn, Joy S Michael, K R John, Saskia den Boon, J Lucian Davis, Andrew Whitelaw, Mark P Nicol, Maria Tarcela Gler, Anar Khaliqov, Carlos Zamudio, Mark D Perkins, Catharina C Boehme, Frank Cobelens
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2011-11-01
Series:PLoS Medicine
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22087078/pdf/?tool=EBI

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22087078/pdf/?tool=EBI

Similar Items